Can you take clozapine while breastfeeding?

What LactMed would consider instead

LactMed ends this record by naming the drugs it would consider in place of clozapine. Whether any of them fits depends on what you are treating — this is the database’s list, not a recommendation from us.

• Haloperidol
• Olanzapine
• Quetiapine
• Risperidone

How much clozapine gets into breastmilk

Maternal Levels. A woman taking oral clozapine 50 mg daily had a milk clozapine level of 63.5 mcg/L one day postpartum. At 3 days postpartum, her dose was increased to 100 mg daily and at 7 days postpartum, clozapine in milk was 115.6 mcg/L. Her infant was not breastfed and timing of the samples with respect to the doses was not stated.

Infant Levels. One woman who took clozapine 100 mg daily in late pregnancy and postpartum partially breastfed her infant for 5 days. The umbilical cord blood clozapine concentration was 56% of the mother's plasma level at birth and infant's serum concentration was 6.5% of the mothers at 33 hours postpartum, implying no drug accumulation, but the timing of the sample with respect to the times of the dosage and nursing was not reported.

What has been seen in breastfed infants

Among 4 infants who were breastfed by mothers taking clozapine, 1 infant experienced drowsiness and 1 infant experienced agranulocytosis possibly caused by clozapine. Details of the cases are lacking.

A healthy female infant was born to a mother who took clozapine 100 mg daily throughout pregnancy and lactation. She was breastfed (extent not stated) up to 1 year of age. The infant developed normally except for speech which was delayed considerably. She did not achieve normal, fluent speech until the age of 5 years. The delayed speech development was possibly related to clozapine in breastmilk, but it could have been the result of exposure to the drug during gestation or could have been unrelated to clozapine.

One woman who took clozapine 100 mg daily in late pregnancy and postpartum partially breastfed her infant for 5 days. No neurodevelopmental disorders were detected in the infant after 32 months of follow-up.

A woman with schizophrenia gave birth and breastfed twice while taking clozapine. The first time, she and the family reported no negative effects on the infant. On the second occasion, she was followed by psychiatrists. She gave birth while taking clozapine 100 mg daily. It was slowly tapered, and olanzapine was begun and titrated to a dose of 20 mg daily. Because of hallucinations, clozapine was restarted and titrated to a dose of 50 mg daily while continuing to breastfeed. Regular follow-up over a year by a pediatrician indicated no agranulocytosis, seizures or neurodevelopmental disorders.

A woman with schizophrenia took clozapine 75 mg daily during pregnancy and postpartum. The woman breastfed (extent not stated) her infant. The infant was followed for 6 months, examined monthly by a pediatrician and had hemograms every 2 weeks. No hematologic or other adverse reactions were seen during this time and the mother noted no adverse effects in the infant.

Patients enlisted in the National Pregnancy Registry for Atypical Antipsychotics who were taking a second-generation antipsychotic drug while breastfeeding (n = 576) were compared to control breastfeeding patients who were not treated with a second-generation antipsychotic (n = 818). Of the patients who were taking a second-generation antipsychotic drug, 60.4% were on more than one psychotropic. A review of the pediatric medical records, no adverse effects were noted among infants exposed or not exposed to second-generation antipsychotic monotherapy or to polytherapy. The number of women taking clozapine was not reported.

A retrospective review of patients in one institution in north India found that of 9 women who received clozapine during pregnancy, three partially breastfed their infants postpartum. No hematological or other adverse outcomes occurred in the infants. Follow-up at a mean of 8.9 months (range 1 to 18 months) found growth to be normal.

Effects on milk supply

Unlike the phenothiazines, clozapine has a minimal effect on maternal serum prolactin levels. However, a woman who had been taking clozapine plus high-dose haloperidol developed hyperprolactinemia and severe galactorrhea 2 weeks after stopping haloperidol and 4 days after starting valproic acid. A dose of cabergoline normalized her serum prolactin and galactorrhea ceased for the following 2 months of observation.

The maternal prolactin level in a mother with established lactation may not affect her ability to breastfeed.

Patients enlisted in the National Pregnancy Registry for Atypical Antipsychotics who were taking a second-generation antipsychotic drug while breastfeeding (n = 576) were compared to control breastfeeding patients who had primarily diagnoses of major depressive disorder and anxiety disorders, most often treated with SSRI or SNRI antidepressants, but not with a second-generation antipsychotic (n = 818). Among women on a second-generation antipsychotic, 60.4% were on more than one psychotropic compared with 24.4% among women in the control group. Of the women on a second-generation antipsychotic, 59.3% reported “ever breastfeeding” compared to 88.2% of women in the control group. At 3 months postpartum, 23% of women on a second-generation antipsychotic were exclusively breastfeeding compared to 47% of women in the control group. The number of women taking clozapine was not reported.